| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |